Elise Durand is a lawyer in the competition law team of Orrick Rambaud Martel’s Paris office. She joined the firm in 2018. Her practice covers all aspects of European and French competition law, both as counsel and in litigation : merger control, anti-competitive practices, and state aid. She has worked on cases involving various sectors, including financial services, energy, retail and pharmaceuticals. Prior to joining Orrick, Elise Durand was an intern in the competition departments of Allen & Overy, DLA Piper and Norton Rose Fulbright, as well as at the European Commission’s Directorate General for Competition.
34
On April 4, 2019, just three months after the publication of the European Commission (EC) report on “Competition enforcement in the pharmaceutical sector,” the French Competition Authority (FrCA) issued its report n°19-A-08 on “Distribution of drugs and private medical biology.” While the (...)
2938
The principles developed by the EU courts in relation to liability for competition law infringements may potentially create important risks for companies in the framework of their M&A transactions. For this reason, antitrust due diligences have become an essential tool allowing companies (...)
